Development and potential use of a monoclonal antibody to the lipopolysaccharide of Pantoea agglomerans (IP-PA1)

Anticancer Research

Volumn 27, Issue 6 A, 2007, Pages 3701-3706

  Taniguchi, Yoshie ^a   Nishizawa, Takashi ^a,b   Honda, Teruko ^c   Yoshioka, Noriko ^a   Inagawa, Hiroyuki ^a,b,d,e   Kohchi, Chie ^a,b,e   Soma, Gen Ichiro ^a,b,e  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b Research and Development Department Macrophi Inc   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d NATIONAL FISHERIES UNIVERSITY   (Japan)

^e TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Enzyme linked immunosorbent assay; IP PA1; Low molecular weight LPS; Monoclonal antibody; Pantoea agglomerans

Indexed keywords

EPITOPE; IMMUNOSTIMULATING AGENT; IP PA1; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; CONFERENCE PAPER; CROSS REACTION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEATING; IMMUNIZATION; IMMUNOPOTENTIATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PANTOEA AGGLOMERANS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYBRIDOMAS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; PANTOEA;

EID: 35348979619     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Kohchi C, Inagawa H, Hino M, Oda M, Nakata K, Yoshida A, Hori H, Terada H, Makino K, Takiguchi K and Soma G: Utilization of macrophages in anticancer therapy: the macrophage network theory. Anticancer Res 24: 3311-3320, 2004.
2. Nishizawa T, Inagawa H, Oshima H, Okutomi T, Tsukioka D, Iguchi M, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. I. Lipopolysaccharide (LPS) from wheat flour: isolation, purification and some biological activities. Chem Pharm Bull (Tokyo) 40: 479-483, 1992.
3. Kohchi C, Inagawa H, Nishizawa T, Yamaguchi T, Nagai S and Soma G: Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory. J Biosci Bioeng 102: 485-496, 2006.
4. Lindh E, Kjaeldgaard P, Frederiksen W and Ursing J: Phenotypical properties of Enterobacter agglomerans (Pantoea agglomerans) from human, animal and plant sources. Apmis 99: 347-352, 1991.
5. Okutomi T, Nishizawa T, Inagawa H, Soma G, Minami M, Satoh M and Mizuno D: Inhibition of morphine dependence by a lipopolysaccharide from Pantoea agglomerans. Eur Cytokine Netw 3: 417-420, 1992.
6. Soma G-I and Mizuno D-I: Further development of the therapy with lipopolysaccharides of a small molecular size on various intractable diseases: a new version of Coley's toxin. In: Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. Fiers W and Buurman W A (eds.) Karger, Basel, pp. 203-220, 1993.
7. Goto S, Sakai S, Kera J, Suma Y, Soma GI and Takeuchi S: Intradermal administration of lipopolysaccharide in treatment of human cancer. Cancer Immunol Immunother 42: 255-261, 1996.
8. Inagawa H, Nishizawa T, Takagi K, Goto S, Soma G and Mizuno D: Antitumor mechanism of intradermal administration of lipopolysaccharide. Anticancer Res 17: 1961-1964, 1997.
9. Inagawa H, Nishizawa T, Noguchi K, Minamimura M, Takagi K, Goto S, Soma G and Mizuno D: Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system. Anticancer Res 17: 2153-2158, 1997.
10. Takahashi Y, Kondo M, Itami T, Honda T, Inagawa H, Nishizawa T, Soma GI and Yokomizo Y: Enhancement of disease resistance against penaeid acute viraemia and induction of virus-inactivating activity in haemolymph of kuruma shrimp, Penaeus japonicus, by oral administration of Pantoea agglomerans lipopolysaccharide (LPS). Fish Shellfish Immunol 10: 555-558, 2000.
11. Itami T, Ohno N, Suzuki N, Doi K, Kondo M, Takahashi Y, Maeda M, Soma G-I, Inagawa H, Honda T and Yokomizo Y: Shrimp hemocytes can produce superoxide and nitric oxide. ITE Lett Batteries, New Technologies & Medicine 2: 70-74, 2001.
12. Zhao ZJ and Liu XM: Preparation of monoclonal antibody and development of enzyme-linked immunosorbent assay specific for Escherichia coli O157 in foods. Biomed Environ Sci 18: 254-259, 2005.
13. Raetz CR: Biochemistry of endotoxins. Annu Rev Biochem 59: 129-170, 1990.
14. Tsukioka D, Nishizawa T, Miyase T, Achiwa K, Suda T, Soma G and Mizuno D: Structural characterization of lipid A obtained from Pantoea agglomerans lipopolysaccharide. FEMS Microbiol Lett 149: 239-244, 1997.
15. Westphal O and Jann K: Bacterial lipopolysaccharides extraction with phenol-water and further application of the procedure. Methods Carbohydr Chem 5: 83-91, 1965.
16. Ciurana B and Tomas JM: Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun 55: 2741-2716, 1987.
17. Honda T, Inagawa H, Fukushima M, Moriyama A and Soma G: Development and characterization of a monoclonal antibody with cross-reactivity towards uracil and thymine, and its potential use in screening patients treated with 5-fluorouracil for possible risks. Clin Chim Acta 322: 59-66, 2002.
18. Feng Y, Shen D and Song W: Rice endophyte Pantoea agglomerans YS19 promotes host plant growth and affects allocations of host photosynthates. J Appl Microbiol 100: 938-945, 2006.
19. Asis CA Jr and Adachi K: Isolation of endophytic diazotroph Pantoea agglomerans and nondiazotroph Enterobacter asburiae from sweetpotato stem in Japan. Lett Appl Microbiol 38: 19-23, 2004.
20. Nunes C, Usall J, Teixido N, Fons E and Vinas I: Post-harvest biological control by Pantoea agglomerans (CPA-2) on Golden Delicious apples. J Appl Microbiol 92: 247-255, 2002.